Spatial Resolution: New Adaptive PET technology yields < 0.6 mm uniform spatial resolution, unrivalled by any other preclinical PET system.
Molecular Sensitivity: With a molecular sensitivity better than coincidence PET and improved spatial resolution, U-PET’s patented Adaptive Stationary Clustered Pinhole PET (SCP-PET) outperforms other preclinical PET designs for a wide range of preclinical imaging applications.
Dynamic PET: Excellent organ- or tissue-specific and whole-body time resolution (0.1 s to 8.0 s) with uniform resolution and S/N across the full selected region of interest.
Sub-mm at All Energies: Unique sub-mm imaging capabilities for high energy isotopes# including radio-therapeutic isotope, i.e. <0.55 mm for 131I, <0.6 mm for 67Ga and <0.7 mm for 213Bi.
Expanded Application Range: With sub-mm resolution and improved S/N characteristics, U-PET enables accurate quantitation at the organ substructure level in mice and rats. Performance will not be affected by co-injected SPECT tracers, making it possible to expand applications beyond the capabilities of conventional coincidence-based PET.
Unmatched PET/SPECT/CT performance: Sub-mm PET and SPECT resolution even when imaged simultaneously in space and time. Anatomical co-registration with fast, ultra-high resolution, low-dose X-ray CT.
Exclusive spatial and temporal co-registration of PET and SPECT images. Sub-mm imaging of co-injected PET and SPECT tracers enables exploring different physiological and molecular functions at the same time, under identical physiological and physical conditions. Allows to switch between SPECT- and PET-based approaches at any time.